A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Gene Expression Profiles and ctDNA for Risk Stratification in Patients With Melanoma
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Ipilimumab and Nivolumab Followed by Adjuvant Nivolumab in Locally Advanced or Limited Metastatic Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Neoadjuvant Immune Checkpoint Blockade + a Prebiotic Food-enriched Dietary Intervention to Optimize Immune Response in Melanoma: NEO-PreFED
- Status
- RECRUITING
- Phase
- PHASE2
A Phase 1b Trial to Evaluate Safety of MB097 in Combination With Pembrolizumab in Melanoma Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Personalised Immunotherapy Platform
- Status
- RECRUITING
- Phase
- N/A
A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Intravenous Iron in Combination With Standard of Care Immunotherapy in Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE2
TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Taste and Smell Dysfunction in Patients More Than Two Years After Start of Immune Checkpoint Inhibitor Therapy
- Status
- COMPLETED
- Phase
- N/A
In Vivo Liquid Biopsy of Melanoma (Cytophone)
- Status
- RECRUITING
- Phase
- NA
Circulating Tumour DNA Guided Adaptive BRAF and MEK Inhibitor Therapy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Melanoma
- Status
- COMPLETED
- Phase
- N/A
A Study in Advanced/Metastatic Solid Tumors With the Study Medicine (PF-07329640) When Given Alone or In Combination
- Status
- TERMINATED
- Phase
- PHASE1
A Trial of AK104 or AK112 in Combination With Axitinib in Patients With Metastatic Mucosal Melanoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Status
- RECRUITING
- Phase
- N/A
Etude rétrospective Monocentrique MATRIX
- Status
- COMPLETED
- Phase
- N/A
LATe TreatmENT Related Toxicity in Melanoma (LATENT)
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2